US biosimilar exp Interchangeable biosimilar - can substitute for reference product wo consulting MD Primary endpt: phar
Tweet Content
US biosimilar exp
Interchangeable biosimilar - can substitute for reference product wo consulting MD
Primary endpt: pharmacokinetic data
61 approved biosimilars
@RheumKay: “pts should share in financial benefits”
Currently 5-87% discount
#PBMReform @ACRheumDC
@RheumNow #ACR24 https://t.co/RqwbZalZko
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off